# Ultra-high Dose Vitamin D for HSCT

> **NCT03759262** · PHASE1 · COMPLETED · sponsor: **Children's Hospital Los Angeles** · enrollment: 33 (actual)

## Conditions studied

- Hematopoietic Stem Cell Transplant

## Interventions

- **DRUG:** Cholecalciferol

## Key facts

- **NCT ID:** NCT03759262
- **Lead sponsor:** Children's Hospital Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-10
- **Primary completion:** 2020-05-10
- **Final completion:** 2020-05-10
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03759262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03759262, "Ultra-high Dose Vitamin D for HSCT". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03759262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*